Work

Dasatinib (BMS-354825), a dual SRC/ABL tyrosine kinase inhibitor, inhibits tumor formation and prevents malignant ascites in a murine model of peritoneal carcinomatosis

Year: 2006

Type: article

Source: Journal of the American College of Surgeons

DOI: 10.1016/j.jamcollsurg.2006.05.229

Authors: Donald Lesslie, Nila Parikh, Ami Shah, Justin Summy, Jose Trevino, David Hong, Nicholas Donato, Francis Lee, Gary Gallick

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Intraperitoneal and Appendiceal Malignancies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2060928284

FWCI: 0.339

Cites:

Cited by: 1

Related to: 10